|
Market Closed -
Hong Kong S.E.
11:08:15 02/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 0.8350 HKD | -4.02% |
|
+3.73% | -21.96% |
| 09-28 | Regent Pacific Unit to Launch Digital Health Platform in US | MT |
| 09-01 | Regent Pacific Gets $4.5 Million Milestone Payment from Fosun Pharma Unit | MT |
| Market Cap | 31.06M 244M 27.73M 25.45M 23.15M 43.4M 2.94B 44.26M 304M 123M 1.55B 117M 114M 4.9B | P/E 2024 |
-2.39x | P/E 2025 | -7.63x |
|---|---|---|---|---|---|
| Enterprise Value | 34.84M 273M 31.11M 28.55M 25.97M 48.68M 3.3B 49.65M 341M 137M 1.74B 131M 128M 5.5B | EV / Sales 2024 |
19.4x | EV / Sales 2025 | 121x |
| Free-Float |
31.54% | Yield 2024 * |
-
| Yield 2025 | - |
Hong Kong S.E.HKD
| Markets | Quality | ||
|---|---|---|---|
Hong Kong S.E.
| 575 | Delayed | |
Deutsche Boerse AG
| RPG | Delayed | |
|
Börse Stuttgart
| RPG | Delayed |
| 1 day | -4.02% | ||
| 1 week | +3.73% | ||
| Current month | -4.02% | ||
| 1 month | -1.18% | ||
| 3 months | -9.24% | ||
| 6 months | +34.68% | ||
| Current year | -21.96% |
| 1 week | 0.82 |  | 0.88 |
| 1 month | 0.8 | | 0.9 |
| Current year | 0.57 | | 1.22 |
| 1 year | 0.57 | | 1.22 |
| 3 years | 0.32 | | 1.24 |
| 5 years | 0.25 | | 3.76 |
| 10 years | 0.25 | | 15.8 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jamie Gibson
CEO | Chief Executive Officer | 60 | 01/05/2002 |
Yui Fui Wong
DFI | Director of Finance/CFO | 51 | 01/01/2011 |
Michael Wyllie
CTO | Chief Tech/Sci/R&D Officer | 75 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Jamie Gibson
BRD | Director/Board Member | 60 | 01/01/2002 |
| Director/Board Member | 62 | 01/06/2000 | |
Jim Mellon
CHM | Chairman | 70 | 01/01/1994 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 6/5/23 A | Other | Director | 3,639,574 | 0.1517% | ||
| 6/5/23 A | Other | Founder | 2,455,657,694 | - | ||
| 6/5/23 A | Other | Chief Executive Officer | 149,249,568 | 6.2202% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.02% | +3.73% | +26.52% | +4.38% | 32.36M | |
| -0.98% | +9.72% | +56.55% | +141.86% | 1,263B | |
| -1.47% | +1.05% | +44.47% | +79.11% | 658B | |
| -2.18% | +0.67% | +36.19% | +101.50% | 521B | |
| -1.54% | +0.18% | +53.06% | +66.79% | 391B | |
| -0.60% | +5.90% | +80.52% | +44.78% | 369B | |
| -1.69% | +3.17% | +32.18% | +55.35% | 307B | |
| -0.72% | +7.83% | +12.10% | +33.76% | 290B | |
| +0.20% | +4.72% | +57.14% | +74.65% | 252B | |
| -0.30% | +7.01% | +39.13% | +109.05% | 212B | |
| Average | -1.35% | +6.12% | +43.79% | +71.12% | 426.2B | |
| Weighted average by Cap. | -1.18% | +6.60% | +48.34% | +92.76% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 719K 5.64M 642K 589K 536K 1M 68.07M 1.02M 7.04M 2.84M 35.93M 2.7M 2.64M 113M | 363K 2.85M 324K 297K 271K 507K 34.37M 517K 3.55M 1.43M 18.14M 1.36M 1.33M 57.29M |
| Net income | -4.48M -35.17M -4M -3.67M -3.34M -6.26M -424M -6.39M -43.86M -17.68M -224M -16.82M -16.46M -707M | -4.71M -36.96M -4.21M -3.86M -3.51M -6.58M -446M -6.71M -46.09M -18.58M -235M -17.68M -17.3M -743M |
| Net Debt | 3.22M 25.24M 2.87M 2.64M 2.4M 4.49M 305M 4.58M 31.48M 12.69M 161M 12.07M 11.82M 508M | 3.78M 29.68M 3.38M 3.1M 2.82M 5.29M 358M 5.39M 37.02M 14.92M 189M 14.2M 13.9M 597M |
Employees
15
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/11/26 | HK$0.8350 | -4.02% | 13,000 |
| 30/10/26 | HK$0.8700 | +2.35% | 30,500 |
| 29/10/26 | HK$0.8500 | 0.00% | 0 |
| 28/10/26 | HK$0.8500 | -3.95% | 20,500 |
| 27/10/26 | HK$0.8850 | 0.00% | 4,500 |
- Stock Market
- Stocks
- 575 Stock
Select your edition
All financial news and data tailored to specific country editions
